Yahoo Web Search

Search results

1. • 

     Drugmaker Merck sues the Biden administration over Medicare's drug price negotiations

     USA TODAY via Yahoo News· 1 year ago

     The drugmaker Merck on Tuesday sued the federal government over Medicare's plans to negotiate lower...

2. • 

     Drugmakers scout for deals, ramp up research spending

     Reuters via Yahoo News· 1 year ago

     Drugmakers including Merck & Co, AstraZeneca Plc and AbbVie Inc said on Thursday they are open to...

3. • 

     Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...

     The Hill via Yahoo Finance· 2 months ago

     A new report from the center-left watchdog group Accountable US found that most major drugmakers...

4. • 

     Column: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's...

     LA Times via Yahoo Finance· 1 year ago

     The big drugmaker Merck wants to stifle Medicare's right to negotiate drug prices. (Mel Evans /...

5. • 

     Merck sues US government to halt Medicare drug price negotiation

     Reuters via Yahoo News· 1 year ago

     NEW YORK (Reuters) -Merck & Co sued the U.S. government on Tuesday, seeking to halt the Medicare...

6. • 

     Drugmakers sign on to negotiate Medicare prices under protest

     Reuters via Yahoo News· 9 months ago

     All the drugmakers that make the 10 prescription medicines subject to the first-ever price...

7. • 

     Merck sues federal government, calling plan to negotiate Medicare drug prices extortion

     Associated Press via Yahoo News· 1 year ago

     Merck is suing the federal government over a plan to negotiate Medicare drug prices, calling the...

8. • 

     Drugmakers brace for list of first 10 drugs for US price negotiations

     Reuters via Yahoo Finance· 11 months ago

     Drugmakers are bracing for the U.S. government's announcement of the 10 prescription medicines that...

9. • 

     Merck, Eisai's combination therapy fails in lung cancer studies

     Reuters via Yahoo News· 9 months ago

     The pairing of Merck's blockbuster immunotherapy Keytruda and Eisai's Lenvima has previously failed...

10. • 

      Merck to buy private biotech Caraway in neuroscience deal

      BioPharma Dive via Yahoo Finance· 7 months ago

      Dive Brief: Merck & Co. will pay as much as $610 million to acquire private biotechnology company...